Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Is Dextroamphetamine recalled?

Yes — there is an active recall. 7 ongoing FDA recalls mention Dextroamphetamine (48 total). Check the affected lots below.

Most common reason: Labeling / mix-up (22 of these recalls)

Recalls are matched by product description. A recall usually affects specific lots, not every package of Dextroamphetamine. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.

Dextroamphetamine recalls in 2026

1 initiated in 2026, 48 in total — newest first
Class II · Moderate risk

Dextroamphetamine Saccharate

Labeling: Label Mix-up: Capsules contain only immediate-release (IR) pellets while labeled as ER capsules.

Ongoing Labeling / mix-up Lannett Company Inc. D-0660-2026
Class II · Moderate risk

Dextroamphetamine Saccharate

Presence of Foreign Tablet/Capsule: Two (2) bottles labeled as Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets, 10mg, 100ct, contained one (1) tablet of Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets, 5 mg.

Completed Particulate / foreign matter Lannett Company Inc. NDC 0527-0762-37 D-0642-2025
Class II · Moderate risk

Xelstrym (dextroamphetamine)

Defective Delivery System: The product does not meet predetermined specifications for Coldflow (adhesive).

Ongoing Packaging defect Noven Pharmaceuticals Inc NDC 68968-0215-3 D-0055-2025
Class II · Moderate risk

Dextroamphetamine Saccharate

Labeling: Label Error on Declared Strength; A sealed 100-count bottle labeled with 15 mg actually contained 100 tablets of 20 mg strength of the drug product.

Terminated Labeling / mix-up Teva Pharmaceuticals USA Inc NDC 0555-0777-02 D-1539-2022
Class III · Low risk

Dextroamphetamine Saccharate

Labeling: Incorrect expiration date. Product dated with 24-month expiration date instead of 18-months.

Terminated Labeling / mix-up ANI Pharmaceuticals, Inc. NDC 43975-282-10 D-0048-2021
Class III · Low risk

Dextroamphetamine Saccharate

Labeling: Incorrect expiration date. Product dated with 24-month expiration date instead of 18-months.

Terminated Labeling / mix-up ANI Pharmaceuticals, Inc. NDC 43975-281-10 D-0047-2021
Class III · Low risk

Dextroamphetamine Saccharate

Labeling: Incorrect expiration date. Product dated with 24-month expiration date instead of 18-months.

Terminated Labeling / mix-up ANI Pharmaceuticals, Inc. NDC 43975-280-10 D-0046-2021
Class III · Low risk

Dextroamphetamine Saccharate

Labeling: Incorrect expiration date. Product dated with 24-month expiration date instead of 18-months.

Terminated Labeling / mix-up ANI Pharmaceuticals, Inc. NDC 43975-279-10 D-0045-2021
Class III · Low risk

Dextroamphetamine Saccharate

Labeling: Incorrect expiration date. Product dated with 24-month expiration date instead of 18-months.

Terminated Labeling / mix-up ANI Pharmaceuticals, Inc. NDC 43975-278-10 D-0044-2021
Class III · Low risk

Dextroamphetamine Saccharate

Labeling: Incorrect expiration date. Product dated with 24-month expiration date instead of 18-months.

Terminated Labeling / mix-up ANI Pharmaceuticals, Inc. NDC 43975-277-10 D-0043-2021
Class II · Moderate risk

Dextroamphetamine Sacharate

Superpotent Drug: Amphetamine Mixed Salts 20mg have been found to be out of specification for weight and thickness.

Terminated Wrong potency / content Aurobindo Pharma USA Inc. NDC 13107-073-01 D-0143-2020
Class II · Moderate risk

Dextroamphetamine Saccharate

Unit Dose Mispackaging; blister cavities may contain more than one tablet /capsule

Terminated Labeling / mix-up Amerisource Health Services NDC 68084-887-32 D-1490-2016
Class II · Moderate risk

Dextroamphetamine Saccharate

Unit Dose Mispackaging; blister cavities may contain more than one tablet /capsule

Terminated Labeling / mix-up Amerisource Health Services NDC 68084-909-32 D-1489-2016
Class II · Moderate risk

Dextroamphetamine Saccharate

Unit Dose Mispackaging; blister cavities may contain more than one tablet /capsule

Terminated Labeling / mix-up Amerisource Health Services NDC 68084-832-25 D-1488-2016
Class II · Moderate risk

Dextroamphetamine Saccharate

Unit Dose Mispackaging; blister cavities may contain more than one tablet /capsule

Terminated Labeling / mix-up Amerisource Health Services NDC 68084-898-32 D-1487-2016
Class II · Moderate risk

Dextroamphetamine Saccharate

Unit Dose Mispackaging; blister cavities may contain more than one tablet /capsule

Terminated Labeling / mix-up Amerisource Health Services NDC 68084-815-25 D-1486-2016